Tokyo, Sept. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062991) titled 'Exploration of Novel Biomarkers Associated with Treatment Response to Biologics in Severe Asthma' on Sept. 20.
Study Type:
Observational
Primary Sponsor:
Institute - Keio University School
Condition:
Condition - Severe asthma, refractory asthma
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - This prospective, single-center observational study enrolls patients with severe asthma treated with biologic agents. Biological samples (sputum, blood, nasal brushing, stool) are collected for multi-omics analysis and for analysis of lymphocytes, eosinophils, and epithelial...